Lymphotoxin-α Gene 252G Allelic Variant Is a Risk Factor for Large-Vessel-Associated Ischemic Stroke

A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular neuroscience Vol. 27; no. 2; pp. 205 - 212
Main Authors Szolnoki, Zoltán, Havasi, Viktória, Talián, Gábor, Bene, Judit, Komlósi, Katalin, Somogyvári, Ferenc, Kondacs, András, Szabó, Mihály, Fodor, Lajos, Bodor, Anita, Melegh, Béla
Format Journal Article
LanguageEnglish
Published United States 2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke.
AbstractList A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke.A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke.
A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the intron 1 252A-->G (252G) transition, which naturally coexists with an exon 3 804C-->A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p<0.025). Specific subclassification of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p<0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role in the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke.
A direct role of lymphotoxin- alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the naturally occurring genetic variants of the LTA gene have been demonstrated to exhibit affected functions, and an allelic difference in binding to transcription factor(s) has also been suggested. The homozygous variant of LTA characterized by the Intron 1 252A arrow right G (252G) transition, which naturally coexists with an exon 3 804C arrow right A (804A) single-nucleotide polymorphism (SNP), has been reported as a susceptibility gene for myocardial infarction. Because the atherosclerotic process is also an integral component in the pathogenesis of certain types of vascular stroke, we investigated the possible significance of the above SNPs in 353 ischemic stroke patients and 180 healthy controls. The homozygous LTA allele with the 252G and 804C SNPs occurred more frequently in stroke patients (13.9%) than in controls (7.20%, p < 0.025). Specific subclasslflcation of the patients revealed an accumulation of these SNPs in large-vessel, pathology-associated cerebral infarction (18.2%); multivariate logistic regression analysis of the data confirmed this association, with an odds ratio of 2.1 (95% confidence interval, 1.3-6.2; p < 0.005). Elimination of all subjects with a history or evidence of ischemic heart disease, including myocardial infarction, did not affect this association. These data show that besides the role In the development of myocardial infarction, the homozygous carriage of the LTA allele with 252G and 804A SNPs is a novel susceptibility factor for largevesselassociated ischemic stroke.
Author Bene, Judit
Somogyvári, Ferenc
Komlósi, Katalin
Bodor, Anita
Szabó, Mihály
Kondacs, András
Szolnoki, Zoltán
Talián, Gábor
Melegh, Béla
Havasi, Viktória
Fodor, Lajos
Author_xml – sequence: 1
  givenname: Zoltán
  surname: Szolnoki
  fullname: Szolnoki, Zoltán
– sequence: 2
  givenname: Viktória
  surname: Havasi
  fullname: Havasi, Viktória
– sequence: 3
  givenname: Gábor
  surname: Talián
  fullname: Talián, Gábor
– sequence: 4
  givenname: Judit
  surname: Bene
  fullname: Bene, Judit
– sequence: 5
  givenname: Katalin
  surname: Komlósi
  fullname: Komlósi, Katalin
– sequence: 6
  givenname: Ferenc
  surname: Somogyvári
  fullname: Somogyvári, Ferenc
– sequence: 7
  givenname: András
  surname: Kondacs
  fullname: Kondacs, András
– sequence: 8
  givenname: Mihály
  surname: Szabó
  fullname: Szabó, Mihály
– sequence: 9
  givenname: Lajos
  surname: Fodor
  fullname: Fodor, Lajos
– sequence: 10
  givenname: Anita
  surname: Bodor
  fullname: Bodor, Anita
– sequence: 11
  givenname: Béla
  surname: Melegh
  fullname: Melegh, Béla
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16186631$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9OGzEQhy2UqgTojTPyqSeW2t61184tQiSAUiqVlqvl9U6KYXcdbEcij8WL9Jkw4o9QhdTDaObwfaPR_HbQaPADILRPyREtJf92_v1iwuoJmzDCt9CYSMULKZQYvZu30U6MN4QwWlH5GW1TQaUQJR0jWGz61bVP_t4Nxd8HPIcBMONsjqddB52z-MoEZ4aEzyI2-KeLt3hmbPIBL3MtTPgDxRXECF0xjdFbZxK0GbbX0Gf7MgV_C3vo09J0Eb689F30e3by6_i0WPyYnx1PF4VlJU8FI7IBKOtatbxpW5MPbkjZ1MCWvC0lq4VgRlAgltSCCaPaSvGKibqivCpJU-6ir897V8HfrSEm3btooevMAH4dtZBZU4T-F6RKSc7VE3jwAq6bHlq9Cq43YaNfP5gB9gzY4GMMsNTWJZOcH1IwrtOU6KeYdI5Js1oznWPK0uE_0tvej_BHY4aRmw
CitedBy_id crossref_primary_10_1136_ard_2007_082594
crossref_primary_10_1016_j_exger_2008_04_006
crossref_primary_10_1542_peds_2007_3758
crossref_primary_10_1016_j_humgen_2022_201126
crossref_primary_10_1161_STROKEAHA_108_524587
crossref_primary_10_1556_CEMED_4_2010_2_2
crossref_primary_10_1186_1471_2164_7_281
crossref_primary_10_1016_j_ccell_2008_01_001
crossref_primary_10_4199_C00052ED1V01Y201204GMM001
crossref_primary_10_1161_STROKEAHA_107_510800
crossref_primary_10_1016_j_clineuro_2008_09_027
crossref_primary_10_1253_circj_72_1065
crossref_primary_10_1556_OH_2011_29113
crossref_primary_10_3109_00207454_2015_1134527
crossref_primary_10_1002_jgm_3229
crossref_primary_10_1007_s11883_006_0072_2
crossref_primary_10_1007_s11011_014_9584_6
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
8FD
FR3
H94
P64
RC3
7X8
DOI 10.1385/JMN:27:2:205
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 0895-8696
EndPage 212
ExternalDocumentID 16186631
10_1385_JMN_27_2_205
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-Y2
.86
.GJ
.VR
06C
06D
0R~
0VX
0VY
1N0
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3SX
4.4
406
408
40D
40E
44B
53G
5GY
5RE
5VS
67N
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACCUX
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACSTC
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFGCZ
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
CITATION
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
H13
HF~
HG6
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
ITM
IWAJR
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M1P
M2M
M4Y
MA-
MVM
N2Q
N9A
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
RNS
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
YLTOR
ZMTXR
ZOVNA
~A9
~EX
-4W
-56
-5G
-BR
-EM
-~C
3V.
ADINQ
CGR
CUY
CVF
ECM
EIF
GQ6
NPM
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z91
7T5
7TK
8FD
ABRTQ
FR3
H94
P64
PJZUB
PPXIY
PUEGO
RC3
7X8
ID FETCH-LOGICAL-c235t-208bee3779d5bdda002b03b7e2f5d3827662a61e0c07626a9d4954267415430b3
ISSN 0895-8696
IngestDate Fri Jul 11 05:09:17 EDT 2025
Sun Aug 24 03:46:26 EDT 2025
Wed Feb 19 01:43:30 EST 2025
Tue Jul 01 03:06:00 EDT 2025
Thu Apr 24 22:55:23 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c235t-208bee3779d5bdda002b03b7e2f5d3827662a61e0c07626a9d4954267415430b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16186631
PQID 19985591
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_68626901
proquest_miscellaneous_19985591
pubmed_primary_16186631
crossref_citationtrail_10_1385_JMN_27_2_205
crossref_primary_10_1385_JMN_27_2_205
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-00-00
PublicationDateYYYYMMDD 2005-01-01
PublicationDate_xml – year: 2005
  text: 2005-00-00
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of molecular neuroscience
PublicationTitleAlternate J Mol Neurosci
PublicationYear 2005
References 1750045 - Stroke. 1991 Nov;22(11):1379-83
12818249 - Thromb Res. 2003 Mar 15;109(5-6):265-9
10539839 - Am Heart J. 1999 Nov;138(5 Pt 2):S419-20
12829866 - Stroke. 2003 Aug;34(8):2050-9
10960044 - Brain. 2000 Sep;123 ( Pt 9):1784-812
9566356 - Neurology. 1998 Apr;50(4):841 and 11 pages following
8640995 - Circulation. 1996 Feb 15;93(4):672-82
9133511 - Circulation. 1997 Apr 15;95(8):2027-31
9180243 - Atherosclerosis. 1997 May;131(1):43-8
534423 - Ann Neurol. 1979 Sep;6(3):245-52
1670638 - J Exp Med. 1991 Jan 1;173(1):209-19
7886710 - Stroke. 1995 Mar;26(3):380-5
8821773 - Inflamm Res. 1996 Jan;45(1):14-9
7774281 - Curr Top Microbiol Immunol. 1995;198:175-218
9416885 - Circulation. 1997 Dec 16;96(12 ):4219-25
14638877 - J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1615-20
12663932 - J Mol Neurosci. 2003 Feb;20(1):31-8
12426569 - Nat Genet. 2002 Dec;32(4):650-4
3344216 - Nucleic Acids Res. 1988 Feb 11;16(3):1215
12382154 - J Neurol. 2002 Oct;249(10):1391-7
11809756 - J Biol Chem. 2002 Apr 5;277(14):12364-8
9183343 - Stroke. 1997 Jun;28(6):1158-64
References_xml – reference: 9183343 - Stroke. 1997 Jun;28(6):1158-64
– reference: 12382154 - J Neurol. 2002 Oct;249(10):1391-7
– reference: 7886710 - Stroke. 1995 Mar;26(3):380-5
– reference: 9180243 - Atherosclerosis. 1997 May;131(1):43-8
– reference: 8821773 - Inflamm Res. 1996 Jan;45(1):14-9
– reference: 7774281 - Curr Top Microbiol Immunol. 1995;198:175-218
– reference: 11809756 - J Biol Chem. 2002 Apr 5;277(14):12364-8
– reference: 1670638 - J Exp Med. 1991 Jan 1;173(1):209-19
– reference: 12818249 - Thromb Res. 2003 Mar 15;109(5-6):265-9
– reference: 534423 - Ann Neurol. 1979 Sep;6(3):245-52
– reference: 9566356 - Neurology. 1998 Apr;50(4):841 and 11 pages following
– reference: 10539839 - Am Heart J. 1999 Nov;138(5 Pt 2):S419-20
– reference: 10960044 - Brain. 2000 Sep;123 ( Pt 9):1784-812
– reference: 12426569 - Nat Genet. 2002 Dec;32(4):650-4
– reference: 12829866 - Stroke. 2003 Aug;34(8):2050-9
– reference: 8640995 - Circulation. 1996 Feb 15;93(4):672-82
– reference: 3344216 - Nucleic Acids Res. 1988 Feb 11;16(3):1215
– reference: 12663932 - J Mol Neurosci. 2003 Feb;20(1):31-8
– reference: 1750045 - Stroke. 1991 Nov;22(11):1379-83
– reference: 9133511 - Circulation. 1997 Apr 15;95(8):2027-31
– reference: 14638877 - J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1615-20
– reference: 9416885 - Circulation. 1997 Dec 16;96(12 ):4219-25
SSID ssj0021418
Score 1.8308024
Snippet A direct role of lymphotoxin-alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the...
A direct role of lymphotoxin- alpha (LTA) in promoting atherosclerotic plaque growth has been demonstrated recently. The different protein transcripts of the...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 205
SubjectTerms Aged
Alleles
Blood Vessels - pathology
Brain Ischemia - genetics
Brain Ischemia - physiopathology
Female
Genetic Predisposition to Disease
Genotype
Humans
Lymphotoxin-alpha - genetics
Lymphotoxin-alpha - metabolism
Male
Middle Aged
Regression Analysis
Risk Factors
Stroke - genetics
Stroke - physiopathology
Title Lymphotoxin-α Gene 252G Allelic Variant Is a Risk Factor for Large-Vessel-Associated Ischemic Stroke
URI https://www.ncbi.nlm.nih.gov/pubmed/16186631
https://www.proquest.com/docview/19985591
https://www.proquest.com/docview/68626901
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9pAEF4Rcumlaps-6CPdQ9uL5RbvYq_hBhU0IOJWwUSoF2ttLxIKsatgqia_vjPrB0YK6uOAQZbtRTOfxzPjmW8IeRcrubTjuGOGittmR4nIRBZyk7uh4NKylzLG1MC555zNO5OFvWg0ZrWqpW0Wfozu7u0r-R-twj7QK3bJ_oNmq4vCDvgN-oUtaBi2f6Xj6S3oIs3SX6vENHTXrKaRNpjNvhj99Vohg_UlRMMgPmO8MaRxgZXkIz1jRxcYTrEQ3LxEAvG1WaoKfNAxBL26bH6W3aRX--VCOxf2upyta9RoMSukzO7SdZLmY7G_7yzdT7lZ7VXX-jrVohP0VXJA5YnWyV5Swq5bra5tuk4-prY0sXn7fwElVreXxamqsJ7sXqvOXSTAmJx7IH4mcIOf8tQ6hbb3NRjNp9PAHy78I3LMIHZgTXLcHw0GXhWHWx2d9q3-adEPAat8gjV6TPRYj-E8w7qnciD80G6I_4g8LIRP-zkYHpOGSp6Qk34is_T6ln6guqJXvyo5Ias6PqjGB0V8UMQHLfBBC3zQ8YZKivigOT4o4IMewAct8UFzfDwl89HQ_3xmFqM1zIhxO4O7yA2VQrLJ2A7jWIJUwjYPhWJw53KXCcdh0rFUO2rD09KR3RgCaXDm0P_s8HbIn5FmkibqBaHR0kVCJSE4EhNJ1bUiZDmM2xHsgudJixilGIOo4J3H8SfrQL9Mde0AhB4wEbAAhN4i76ujf-R8KweOe1tqJACDiG-5ZKLS7SbAplEIk63DR2BTFM5ha5HnuSp3K-H0CIdbL_949VfkgSbx1cm416SZ3WzVG3BPs_CUHImFOC1AB9-Dofft4jdGM5HA
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lymphotoxin-+alpha+Gene+252G+Allelic+Variant+Is+a+Risk+Factor+for+Large-Vessel-Associated+Ischemic+Stroke&rft.jtitle=Journal+of+molecular+neuroscience&rft.au=Szolnoki%2C+Z&rft.au=Havasi%2C+V&rft.au=Talian%2C+G&rft.au=Bene%2C+J&rft.date=2005&rft.issn=0895-8696&rft.volume=27&rft.issue=2&rft.spage=205&rft.epage=212&rft_id=info:doi/10.1385%2FJMN%3A27%3A2%3A205&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-8696&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-8696&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-8696&client=summon